- Home
- HST vs ELAN Comparison
HST vs ELAN Comparison
Compare HST & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HST
- ELAN
- Stock Information
- Founded
- HST 1927
- ELAN 1954
- Country
- HST United States
- ELAN United States
- Employees
- HST N/A
- ELAN N/A
- Industry
- HST Real Estate Investment Trusts
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- HST Real Estate
- ELAN Health Care
- Exchange
- HST Nasdaq
- ELAN Nasdaq
- Market Cap
- HST 10.0B
- ELAN 9.5B
- IPO Year
- HST N/A
- ELAN 2018
- Fundamental
- Price
- HST $16.91
- ELAN $20.65
- Analyst Decision
- HST Buy
- ELAN Buy
- Analyst Count
- HST 13
- ELAN 7
- Target Price
- HST $18.04
- ELAN $18.33
- AVG Volume (30 Days)
- HST 8.9M
- ELAN 5.7M
- Earning Date
- HST 11-05-2025
- ELAN 11-05-2025
- Dividend Yield
- HST 5.32%
- ELAN N/A
- EPS Growth
- HST N/A
- ELAN N/A
- EPS
- HST 0.94
- ELAN 0.88
- Revenue
- HST $5,938,000,000.00
- ELAN $4,484,000,000.00
- Revenue This Year
- HST $5.78
- ELAN $5.59
- Revenue Next Year
- HST $1.68
- ELAN $4.89
- P/E Ratio
- HST $18.04
- ELAN $23.58
- Revenue Growth
- HST 8.38
- ELAN N/A
- 52 Week Low
- HST $12.22
- ELAN $8.02
- 52 Week High
- HST $19.37
- ELAN $20.92
- Technical
- Relative Strength Index (RSI)
- HST 43.80
- ELAN 70.00
- Support Level
- HST $16.86
- ELAN $18.48
- Resistance Level
- HST $17.66
- ELAN $19.35
- Average True Range (ATR)
- HST 0.33
- ELAN 0.59
- MACD
- HST -0.11
- ELAN 0.11
- Stochastic Oscillator
- HST 4.81
- ELAN 89.81
About HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 81 predominantly urban and resort upper-upscale and luxury hotel properties representing over 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.